Ghent University Academic Bibliography

Your filters: cql: issn exact "0008-5472"

Add to list
Immunotherapeutic targeting and PET imaging of DLL3 in small-cell neuroendocrine prostate cancer

Jonathan Chou, Emily A. Egusa, Sinan Wang, Michelle L. Badura, Fei Lee, Anil P. Bidkar, Jun Zhu, Tanushree Shenoy, Kai Trepka, Troy M. Robinson, et al.

(2023) CANCER RESEARCH. 83(2). p.301-315
Add to list
- Journal Article
- A1
- open access
Whole slide imaging-based prediction of TP53 mutations identifies an aggressive disease phenotype in prostate cancer

Marija Pizurica (UGent) , Maarten Larmuseau (UGent) , Kim Van der Eecken, Louise de Schaetzen van Brienen (UGent) , Francisco Carrillo-Perez, Simon Isphording (UGent) , Nicolaas Lumen (UGent) , Jo Van Dorpe (UGent) , Piet Ost (UGent) , Sofie Verbeke (UGent) , et al.

(2023) CANCER RESEARCH. 83(17). p.2970-2984
Add to list
- Conference Paper
- C3
Overcoming complex polyclonality for accurate clinical genotyping in metastatic prostate cancer

Alexander W. Wyatt, Andrew J. Murtha, Evan Warner, Kim Van der Eecken, Edmond M. Kwan, Cameron Herberts, Joonatan Sipola, Sarah W. S. Ng, Xinyi E. Chen, Nicolette M. Fonseca, et al.

(2023) CANCER RESEARCH. In Cancer Research 83(11, Supplement S).
Add to list
- Conference Paper
- C3
WSI based prediction of TP53 mutations identifies aggressive disease phenotype in prostate cancer

Marija Pizurica (UGent) , Maarten Larmuseau (UGent) , Kim Van der Eecken, Louise de Schaetzen van Brienen (UGent) , Francisco Carrillo-Perez, Simon Isphording, Nicolaas Lumen (UGent) , Jo Van Dorpe (UGent) , Piet Ost (UGent) , Sofie Verbeke (UGent) , et al.

(2023) CANCER RESEARCH. In Cancer Research 83(8, Supplement S).
Add to list
- Journal Article
- A1
- open access
Quantification of neoantigen-mediated immunoediting in cancer evolution : letter

Arne Claeys (UGent) and Jimmy Van den Eynden (UGent)

(2023) CANCER RESEARCH. 83(6). p.971-972
Add to list
- Journal Article
- A1
- open access
Efficacy of CD40 agonists is mediated by distinct cDC subsets and subverted by suppressive macrophages

Aleksandar Murgaski, Mate Kiss, Helena Van Damme, Daliya Kancheva, Isaure Vanmeerbeek, Jiri Keirsse, Eva Hadadi, Jan Brughmans, Sana M. Arnouk, Ahmed E. I. Hamouda, et al.

(2022) CANCER RESEARCH. 82(20). p.3785-3801
Add to list
- Miscellaneous
Heterogeneity of CAFfeinated tumors : sweet targeting perspectives

Olivier De Wever (UGent)

(2022) CANCER RESEARCH. 82(4). p.537-538
Add to list
Loss-of-function mutations in TRAF7 and KLF4 cooperatively activate RAS-like GTPase signaling and promote meningioma development

P Najm, P Zhao, M Steklov, RN Sewduth, MF Baietti, S Pandolfi, N Criem, B Lechat, Teresa Maia (UGent) , Delphi Van Haver (UGent) , et al.

(2021) CANCER RESEARCH. 81(16). p.4218-4229
Add to list
- Conference Paper
- C3
Adherence to and patient satisfaction with the combination therapy of exemestane and everolimus in postmenopausal women with HR+ HER2- advanced breast cancer : results from the IPSOC-mamma study

Veerle Foulon, Carrie Visser, Sandra De Coster, Lise-Marie Kinnaer (UGent) , Ellen Reynders, Anne Deblander, Patrick Berteloot, Kevin Punie, Hans Wildiers, Veronique Cocquyt (UGent) , et al.

(2021) CANCER RESEARCH. In Cancer Research 81(4, Supplement S).
Add to list
Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness

Vivek L. Patel, Evan L. Busch, Tara M. Friebel, Angel Cronin, Goska Leslie, Lesley McGuffog, Julian Adlard, Simona Agata, Bjarni A. Agnarsson, Munaza Ahmed, et al.

(2020) CANCER RESEARCH. 80(3). p.624-638

Academic Bibliography

Immunotherapeutic targeting and PET imaging of DLL3 in small-cell neuroendocrine prostate cancer

Whole slide imaging-based prediction of TP53 mutations identifies an aggressive disease phenotype in prostate cancer

Overcoming complex polyclonality for accurate clinical genotyping in metastatic prostate cancer

WSI based prediction of TP53 mutations identifies aggressive disease phenotype in prostate cancer

Quantification of neoantigen-mediated immunoediting in cancer evolution : letter

Efficacy of CD40 agonists is mediated by distinct cDC subsets and subverted by suppressive macrophages

Heterogeneity of CAFfeinated tumors : sweet targeting perspectives

Loss-of-function mutations in TRAF7 and KLF4 cooperatively activate RAS-like GTPase signaling and promote meningioma development

Adherence to and patient satisfaction with the combination therapy of exemestane and everolimus in postmenopausal women with HR+ HER2- advanced breast cancer : results from the IPSOC-mamma study

Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness

Contents

Support

Contact